Berlin, 14 April 2021 - Epimune announces its attendance at the Clinical Immunology Society (CIS) 2021 Virtual Annual Meeting (14-17 Apr 2021).
Two of Epimune's clinical collaborators will present new data using its epigenetic immune cell quantification technology.
Researchers at The Center for Chronic Immunodeficiency (CCI) of the Medical Center - University of Freiburg will present data on the comparison of Epimune's epigenetic immune cell quantification with flow cytometry in a cohort of more than 240 patients with primary immunodeficiency.
Epimune's collaborators at the Leiden University Medical Center will present their data on epigenetic immune cell counting as a second-tier test option in newborn screening for inborn errors of immunity.
Epimune will also be exhibiting at the event.